Specialty Pharmaceuticals Canada

A Bold New Allergan

On March 17, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma.

 

For information about our brand products in Canada, please visit www.allergan.ca